5-(3,4-dihydroxybenzylidene)-1,3-dimethylpyrimidine-2,4,6(1H,3H,5H)-trione

ID: ALA5279417

Max Phase: Preclinical

Molecular Formula: C13H12N2O5

Molecular Weight: 276.25

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN1C(=O)C(=Cc2ccc(O)c(O)c2)C(=O)N(C)C1=O

Standard InChI:  InChI=1S/C13H12N2O5/c1-14-11(18)8(12(19)15(2)13(14)20)5-7-3-4-9(16)10(17)6-7/h3-6,16-17H,1-2H3

Standard InChI Key:  SEPYQEWJGGPRMA-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 20 21  0  0  0  0  0  0  0  0999 V2000
    0.0013   -0.8257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7159   -0.4134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4278   -0.8253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4278   -1.6505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7177   -2.0623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0013   -1.6542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7132   -0.4131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7132    0.4120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4279    0.8245    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4279    1.6498    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7132    2.0623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.0013    1.6498    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.0013    0.8246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1425    2.0623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7159    2.0623    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7132    2.8875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1425    0.4120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7159    0.4120    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7177   -2.8875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1425   -2.0630    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  1  7  1  0
  7  8  2  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 12 11  1  0
 13 12  1  0
  8 13  1  0
 10 14  1  0
 12 15  1  0
 11 16  2  0
  9 17  2  0
 13 18  2  0
  5 19  1  0
  4 20  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5279417

    ---

Associated Targets(non-human)

H9c2 (3506 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 276.25Molecular Weight (Monoisotopic): 276.0746AlogP: 0.53#Rotatable Bonds: 1
Polar Surface Area: 98.15Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 9.13CX Basic pKa: CX LogP: 0.62CX LogD: 0.62
Aromatic Rings: 1Heavy Atoms: 20QED Weighted: 0.44Np Likeness Score: -0.21

References

1. Shi YY, Wei B, Zhou J, Yin ZL, Zhao F, Peng YJ, Yu QW, Wang XL, Chen YJ..  (2022)  Discovery of 5-(3,4-dihydroxybenzylidene)-1,3-dimethylpyrimidine- 2,4,6(1H,3H,5H)-trione as a novel and effective cardioprotective agent via dual anti-inflammatory and anti-oxidative activities.,  244  [PMID:36274277] [10.1016/j.ejmech.2022.114848]

Source